About MaSTherCell
MaSTherCell is a company based in Charleroi (Belgium) founded in 2011 was acquired by Catalent in February 2020.. MaSTherCell has raised $17.37 million across 2 funding rounds from investors including Catalent, Hearst and Orgenesis. The company has 329 employees as of June 30, 2022. MaSTherCell offers products and services including Cosmetic Treatments and Consultations. MaSTherCell operates in a competitive market with competitors including Orgenesis, Ori Biotech, Cognate Bioservices, SpliSense and eXmoor, among others.
- Headquarter Charleroi, Belgium
- Employees 329 as on 30 Jun, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Catalent Gosselies
-
Annual Revenue
$65.41 M (USD)44as on Jun 30, 2022
-
Net Profit
$-10.38 M (USD)-38as on Jun 30, 2022
-
EBITDA
$-10.28 M (USD)-37as on Jun 30, 2022
-
Total Equity Funding
$17.37 M (USD)
in 2 rounds
-
Latest Funding Round
$11.8 M (USD), Series A
Jun 29, 2018
-
Investors
Catalent
& 6 more
-
Employee Count
329
as on Jun 30, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MaSTherCell
MaSTherCell offers a comprehensive portfolio of products and services, including Cosmetic Treatments and Consultations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers non-surgical cosmetic services using evidence-based protocols for client satisfaction.
Provides personalized advice and treatment planning for cosmetic medical needs.
Funding Insights of MaSTherCell
MaSTherCell has successfully raised a total of $17.37M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.8 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $11.8M
-
First Round
First Round
(01 Jun 2011)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Series A - MaSTherCell | Valuation | Great Point Partners | |
| Jun, 2011 | Amount | Seed - MaSTherCell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MaSTherCell
MaSTherCell has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Catalent, Hearst and Orgenesis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on company buyouts
|
Founded Year | Domain | Location | |
|
Early to late-stage tech investments are made globally by REV.
|
Founded Year | Domain | Location | |
|
VC & PE fund
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MaSTherCell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MaSTherCell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Masthercell Comparisons
Competitors of MaSTherCell
MaSTherCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, Cognate Bioservices, SpliSense and eXmoor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
Limited information available
|
|
| domain | founded_year | HQ Location |
Cell and gene therapeutic services are provided to biopharmaceutical firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Masthercell
Frequently Asked Questions about MaSTherCell
When was MaSTherCell founded?
MaSTherCell was founded in 2011.
Where is MaSTherCell located?
MaSTherCell is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Is MaSTherCell a funded company?
MaSTherCell is a funded company, having raised a total of $17.37M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5.57M, raised on Jun 01, 2011.
How many employees does MaSTherCell have?
As of Jun 30, 2022, the latest employee count at MaSTherCell is 329.
What is the annual revenue of MaSTherCell?
Annual revenue of MaSTherCell is $65.41M as on Jun 30, 2022.
What does MaSTherCell do?
MaSTherCell (Manufacturing Synergies for Therapeutic Cells) is a Belgian Contract Development and Manufacturing Organisation, offering its services for the development of cell therapy products. Companys services include process and assay development, GMP manufacturing and quality control services of cell therapy products. The companys services can be availed right from Phase - I to commercialization of the product. Their facilities are authorized by Belgian Drug Agency (AFMPS). The company claims that their quality control services are performed in accordance with European and US pharmacopeia, FDA and EMA. MaSTherCell was acquired by Orgenesis (a company offering cellular therapy and regenerative medicines for the treatment of Type 1 Diabetes) in March 2015. In August 2016, the company was selected by Adaptimmune as a supplier of cell therapy products for use in Adaptimmunes clinical trials.
Who are the top competitors of MaSTherCell?
MaSTherCell's top competitors include Ori Biotech, OBiO Technology and Genflow Biosciences.
What products or services does MaSTherCell offer?
MaSTherCell offers Cosmetic Treatments and Consultations.
Who are MaSTherCell's investors?
MaSTherCell has 7 investors. Key investors include Catalent, Hearst, Orgenesis, Biowin, and Great Point Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.